QIAGEN is a global leader in molecular diagnostics and life sciences, enabling laboratories, researchers, and clinicians to unlock critical insights from biological samples. Founded in 1984, QIAGEN delivers a comprehensive portfolio of sample-to-insight technologies—including sample preparation, digital PCR, next-generation sequencing (NGS), molecular testing panels, automation systems, and advanced bioinformatics. The company’s flagship platforms, such as **QIAcuity digital PCR**, **QIAstat-Dx...